Legal status · Australia
Is Elamipretide legal in Australia?
No. Elamipretide is not an approved medicine in Australia; its classification is "Not registered". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Elamipretide in Australia at a glance
| Classification | Not registered |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Elamipretide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing Elamipretide is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What Elamipretide is
An investigational mitochondria-targeting peptide studied for rare mitochondrial disease and age-related organ decline.
Elamipretide concentrates in the inner mitochondrial membrane by binding cardiolipin, aiming to restore efficient energy production. It has been studied in clinical trials for primary mitochondrial myopathy, Barth syndrome, and dry age-related macular degeneration, with mixed results.
Mechanism: Binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and improving electron transport efficiency and ATP production.
Regulatory history: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Elamipretide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Elamipretide in other countries
United States
Approved medicineFDA-approved (Forzinity, Barth syndrome only), prescription only; other uses investigational
Is Elamipretide legal in the United States?United Kingdom
Not approvedNot licensed
Is Elamipretide legal in the United Kingdom?Canada
Not approvedNot approved
Is Elamipretide legal in Canada?Frequently asked questions
Is Elamipretide legal in Australia?
No. Elamipretide is not an approved medicine in Australia; its classification is "Not registered". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.
Can I buy Elamipretide in Australia?
No approved product exists to buy. In Australia Elamipretide is classified as "Not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Elamipretide TGA approved?
No. In Australia Elamipretide is classified as "Not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: FDA-approved September 19, 2025 as Forzinity (accelerated approval) for Barth syndrome; other uses investigational. Evidence level: Moderate.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Elamipretide live on its compound profile.
Elamipretide profileThis page is general information about the regulatory status of Elamipretide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.